Westaim Management to Look at ‘Strategic Alternatives’
Reeling from its weakened share price, Westaim Corporation, a Canadian company that makes wound care and pharmaceutical products from nanotechnology, is taking a closer look at its business […]
High Hopes for New Prostate-Cancer Test
Results released today from a study of a new test for prostate cancer have raised spirits in the medical community and at the private Seattle firm […]
AFP Captures Italian Firm’s 3-D Imaging Device
AFP Imaging Corporation, of Elmsford, NY, has successfully completed the acquisition of Quantitative Radiology (QR), an Italian firm for which AFP has been the exclusive […]
Yulex Expands Beyond Surgical Gloves
The latest issue of Fast Company has a profile of Yulex Corporation, a Carlsbad, CA, company known for making latex products that are safe for […]
CryoCor Raises $5.45 Million in Private Placement
San Diego-based CryoCor has raised $5.45 million in a private placement with a group of accredited investors. The company sold 1,052,423 shares of common stock […]
Governor Welcomes VCs to Pennsylvania
The governor of Pennsylvania has launched a new program to help attract venture capital to the state’s emerging companies, including those in the life sciences field. […]
Iapyx Introduces Catheter Stabilization Devices
Iapyx Medical, a San Diego firm that makes single-use medical devices, today introduced two products for reducing the risk of common hospital-acquired infections. The Stable-Line […]
Strongest Quarter Ever for Life Sciences Venture Funding
Life sciences venture funding reached an all-time high in the first quarter of 2007, with 36% of total investments going toward the sector. Medical device […]
When’s the Right Time to Hire a PR Pro?
Jim Weinrebe has been doing healthcare PR and marketing for over 20 years. In his current role as senior vice president at Schwartz Communications, Weinrebe […]
Sights Set on Advancing Treatment for Retinal Disease
A piece from the current issue of The American focuses on three small med tech firms’ efforts to reverse blindness — and the challenges such companies face […]